Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02261259 · ClinicalTrials.gov registry record · NA

Effects of Osteopathic Manipulative Treatment on Neuromuscular Control of the Head-neck System

A NA study, sponsored by Michigan State University.

Completed
Registry status
NA
Development phase
154
Enrollment target

NCT02261259: Completed NA study, sponsored by Michigan State University.

NCT02261259 is a NA study that has completed, run by Michigan State University. The registered enrollment target is 154 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02261259, a NA study, has completed, sponsored by Michigan State University.

COMPLETED
Registry status
NA
Development phase
154 participants
Enrollment target

Study Summary

The overall goal of this project is to develop sensitive and objective clinical research tools for the assessment of head-neck motor control. In order to accomplish this goal, the investigators aim to quantify changes in head-neck motor control before and after osteopathic manipulative treatment. The investigators hypothesize that head-neck motor control will improve in neck pain participants after 4-weeks of treatment. Additionally, the investigators will compare position and force head-neck motor control between healthy controls and neck pain patients. The investigators hypothesize that baseline tests of position and force head-neck motor control will be better in healthy individuals than neck pain patients.

Primary Outcome

Participants will be seated in an upright position with their upper body secured to a backrest and will wear a head harness with an attached position sensor. The angular position of the head will be displayed on a monitor 1 meter in front of the participants and they will be asked to follow a moving target by moving their head. Accuracy will be determined by taking the difference between the target position signal and the actual head position (measured in degrees with string potentiometers).

Interventions

  • PROCEDURE Osteopathic manipulative treatment

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2014-06-01
Est. Completion 2017-11-13
Phase NA
Michigan State University

120 total trials

What the finished NCT02261259 record still lists

NCT02261259 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which Osteopathic manipulative treatment is the first listed.

NCT02261259 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02261259 about?

NCT02261259 is a clinical study titled "Effects of Osteopathic Manipulative Treatment on Neuromuscular Control of the Head-neck System". The overall goal of this project is to develop sensitive and objective clinical research tools for the assessment of head-neck motor control. In order to accomplish this goal, the investigators aim to quantify changes in head-neck motor control before and after osteopathic manipulative treatment. Th...

What is the current status of trial NCT02261259?

This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2014-06-01. Estimated completion is 2017-11-13.

What interventions are being tested in trial NCT02261259?

The interventions under investigation include: Osteopathic manipulative treatment (PROCEDURE).

Who is sponsoring clinical trial NCT02261259?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02261259's enrollment target sits among peer trials

154 656th of 2000 higher than 1,345 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04300998 · 154 participants

    Study of CAR-T Therapy in Older Patients

  • NCT04597372 · 154 participants · Phase 2

    Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

  • NCT05294042 · 154 participants · NA

    Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities

  • NCT05512390 · 154 participants · Phase 1

    A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02261259, the US trial registry maintained by the National Library of Medicine. NCT02261259 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.